Maria Katsogiannou
Claudia Andrieu1,2,3,4
Palma Rocchi- 1Institut National de la Santé et de la Recherche Médicale, Unités Mixtes de Recherche 1068, Centre de Recherche en Cancérologie de Marseille, Marseille, France
- 2Institut Paoli-Calmettes, Marseille, France
- 3Centre de Recherche en Cancérologie de Marseille, Institut National de la Santé et de la Recherche Médicale Unités Mixtes de Recherche 1068, Aix-Marseille Université, Marseille, France
- 4Centre National de la Recherche Scientifique, Unités Mixtes de Recherche 7258, Centre de Recherche en Cancérologie de Marseille, Marseille, France
A Correction on
Heat shock protein 27 phosphorylation state is associated with cancer progression
by Katsogiannou M, Andrieu C and Rocchi P (2014). Front. Genet. 5:346. doi: 10.3389/fgene.2014.00346
The conflict of interest statement was erroneously given as “The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.” The correct conflict of interest statement is “The University of British Columbia has submitted patent applications on Apatorsen, an antisense inhibitor of Hsp27, listing PR as an inventor. This IP has been licensed to OncoGenex Technologies, a Vancouver-based biotechnology company. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”
The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: Hsp27, phosphorylation, stress-induced, cancer, apoptosis resistance
Citation: Katsogiannou M, Andrieu C and Rocchi P (2025) Correction: Heat shock protein 27 phosphorylation state is associated with cancer progression. Front. Genet. 16:1703072. doi: 10.3389/fgene.2025.1703072
Received: 10 September 2025; Accepted: 23 September 2025;
Published: 23 October 2025.
Edited and reviewed by:
Andreas Zanzoni, Aix-Marseille Université, FranceCopyright © 2025 Katsogiannou, Andrieu and Rocchi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Palma Rocchi, cGFsbWEucm9jY2hpQGluc2VybS5mcg==; Maria Katsogiannou, bWFyaWEua2F0c29naWFubm91QGluc2VybS5mcg==